Competition rules and health care players: principles and consequences

Author:

Fornaciari Diego,Callens Stefaan

Abstract

PurposeCompetition rules maximise consumer welfare by promoting efficient use of scarce resource and thus high output, low prices, high quality, varied services, innovation, production and distribution. European courts consider doctors and hospital staff as undertakings (any entity that performs economic activities), so that if they enter into agreements then they have to comply with competition rules. This paper's objective is to determine whether competition law, which applies to undertakings, can in fact be applied to different healthcare‐sector players and whether specific rules are needed regarding competition between healthcare undertakings.Design/methodology/approachData were selected from relevant European and national case law, European institution legal documents (such as regulations, guidelines and communications) and healthcare competition law literature, and then examined.FindingsThe paper finds that competition rules are applicable to healthcare players considering the consequences if competition rules are applied to the healthcare market. For market processes to result in the appropriate cost, quality and output, competition law must be proactive. In other words, quality must be fully factored into the competitive mix, allowing consumers to weigh healthcare price and non‐price characteristics.Research limitations/implicationsCountries have different healthcare system and competition rules (although similar), competition rule impact is different for each country. Some healthcare systems are more regulated and there will be less opportunity for healthcare players to compete.Practical implicationsEfficiently applying competition law to healthcare players means that several challenges need facing, such as healthcare quality complexity and court scepticism.Originality/valueThis article points out the challenges when competition law is applied to the healthcare sector and how these challenges are faced in certain countries such as The Netherlands.

Publisher

Emerald

Subject

Health Policy,General Business, Management and Accounting

Reference18 articles.

1. ABA Publishing (2004), Antitrust Healthcare Handbook, 3rd ed., ABA Section of Antitrust Law, ABA Publishing, Chicago, IL.

2. Callens, S. and Fornaciari, D. (2008), “Mededinging en gezondheidszorg”, in Callens, S. and Peers, J. (Eds), Organisatie van de gezondheidszorg, Intersentia, Antwerp and Oxford, pp. 637‐60.

3. Cannon, M. and Tanner, M. (2005), Healthy Competition, What's Holding back Healthcare and How to Free It, Cato Institute, Washington, DC.

4. Custers, T., Aarah, O.A. and Klazinga, N.S. (2006), “Is there a business case for quality in The Netherlands? a critical analysis of the recent reforms of the healthcare system”, Health Policy, Vol. 82 No. 2, pp. 226‐39.

5. Darba, J. and Rovira, J. (1998), “Parallel imports of pharmaceuticals in the European Union”, Pharmacoeconomics, Vol. 14, pp. 129‐36.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Dynamic modelling of national healthcare system;Measuring Business Excellence;2015-08-17

2. A Contingency Approach to the Strategic Management of Intangible Resources;Journal of General Management;2012-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3